other_material
confidence high
sentiment negative
materiality 0.70
Outlook Therapeutics closes $5.0M offering of common stock and warrants
Outlook Therapeutics, Inc.
- 20M shares + 20M warrants sold at $0.25/unit; gross proceeds ~$5.0M, net ~$4.0M.
- Warrants exercisable immediately at $0.25, expire in 5 years; includes 4.99%/9.99% beneficial ownership limitation.
- H.C. Wainwright placement agent, receiving 7% cash fee and 1.4M warrants at $0.3125.
- Company agreed to one-year ban on variable rate transactions and lock-up agreements.
- Offering closed March 25, 2026; net proceeds ~$4.0M for general corporate purposes.